Download website data in JSON data format
Submitted by Anonymous (not verified) on 10 April 2026 - 8:45
Download website data in JSON data format
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 16:38
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 39, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 16:10
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 16:05
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 16:03
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 16:00
Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Fylrevy, estetrol, Date of authorisation: 26/03/2026, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 15:45
Human medicines European public assessment report (EPAR): Fylrevy, estetrol, Date of authorisation: 26/03/2026, Status: Authorised
Union Product Database
Submitted by Anonymous (not verified) on 9 April 2026 - 15:42
Union Product Database
ECIM 2027 is Taking Place in Paris!
Submitted by Catalina on 9 April 2026 - 14:34
We are delighted to announce that the 25th edition of the European Congress of Internal Medicine (ECIM 2027) will take place in Paris from 31 March to 3 April 2027.
Join us at the iconic Cité des sciences et de l'industrie for an enriching and engaging scientific experience. The congress will feature a comprehensive programme including scientific sessions, keynote lectures, interactive workshops, clinical case discussions, and poster presentations.
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 9 April 2026 - 14:08
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 16, Status: Authorised